219 related articles for article (PubMed ID: 18373740)
1. Mesenchymal stem cells expressing TRAIL lead to tumour growth inhibition in an experimental lung cancer model.
Mohr A; Lyons M; Deedigan L; Harte T; Shaw G; Howard L; Barry F; O'Brien T; Zwacka R
J Cell Mol Med; 2008 Dec; 12(6B):2628-43. PubMed ID: 18373740
[TBL] [Abstract][Full Text] [Related]
2. Human mesenchymal stem cells with adenovirus-mediated TRAIL gene transduction have antitumor effects on esophageal cancer cell line Eca-109.
Li L; Li F; Tian H; Yue W; Li S; Chen G
Acta Biochim Biophys Sin (Shanghai); 2014 Jun; 46(6):471-6. PubMed ID: 24739635
[TBL] [Abstract][Full Text] [Related]
3. Growth inhibition of colorectal carcinoma by lentiviral TRAIL-transgenic human mesenchymal stem cells requires their substantial intratumoral presence.
Luetzkendorf J; Mueller LP; Mueller T; Caysa H; Nerger K; Schmoll HJ
J Cell Mol Med; 2010 Sep; 14(9):2292-304. PubMed ID: 19508388
[TBL] [Abstract][Full Text] [Related]
4. Targeting lung cancer stem-like cells with TRAIL gene armed oncolytic adenovirus.
Yang Y; Xu H; Huang W; Ding M; Xiao J; Yang D; Li H; Liu XY; Chu L
J Cell Mol Med; 2015 May; 19(5):915-23. PubMed ID: 25683371
[TBL] [Abstract][Full Text] [Related]
5. Mesenchymal stem cells engineered by modified polyethylenimine polymer for targeted cancer gene therapy, in vitro and in vivo.
Salmasi Z; Hashemi M; Mahdipour E; Nourani H; Abnous K; Ramezani M
Biotechnol Prog; 2020 Nov; 36(6):e3025. PubMed ID: 32410328
[TBL] [Abstract][Full Text] [Related]
6. Mesenchymal stem cell delivery of TRAIL can eliminate metastatic cancer.
Loebinger MR; Eddaoudi A; Davies D; Janes SM
Cancer Res; 2009 May; 69(10):4134-42. PubMed ID: 19435900
[TBL] [Abstract][Full Text] [Related]
7. Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-related, apoptosis-inducing, ligand-engineered human mesenchymal stem cells.
Yang B; Wu X; Mao Y; Bao W; Gao L; Zhou P; Xie R; Zhou L; Zhu J
Neurosurgery; 2009 Sep; 65(3):610-24; discussion 624. PubMed ID: 19687708
[TBL] [Abstract][Full Text] [Related]
8. Antitumor effects of TRAIL-expressing mesenchymal stromal cells in a mouse xenograft model of human mesothelioma.
Lathrop MJ; Sage EK; Macura SL; Brooks EM; Cruz F; Bonenfant NR; Sokocevic D; MacPherson MB; Beuschel SL; Dunaway CW; Shukla A; Janes SM; Steele C; Mossman BT; Weiss DJ
Cancer Gene Ther; 2015 Jan; 22(1):44-54. PubMed ID: 25525034
[TBL] [Abstract][Full Text] [Related]
9. Mesenchymal stromal cell delivery of full-length tumor necrosis factor-related apoptosis-inducing ligand is superior to soluble type for cancer therapy.
Yuan Z; Kolluri KK; Sage EK; Gowers KH; Janes SM
Cytotherapy; 2015 Jul; 17(7):885-96. PubMed ID: 25888191
[TBL] [Abstract][Full Text] [Related]
10. IFN-γ-secreting-mesenchymal stem cells exert an antitumor effect in vivo via the TRAIL pathway.
Yang X; Du J; Xu X; Xu C; Song W
J Immunol Res; 2014; 2014():318098. PubMed ID: 24971369
[TBL] [Abstract][Full Text] [Related]
11. TRAIL-expressing gingival-derived mesenchymal stem cells inhibit tumorigenesis of tongue squamous cell carcinoma.
Xia L; Peng R; Leng W; Jia R; Zeng X; Yang X; Fan M
J Dent Res; 2015 Jan; 94(1):219-28. PubMed ID: 25391621
[TBL] [Abstract][Full Text] [Related]
12. Systemic but not topical TRAIL-expressing mesenchymal stem cells reduce tumour growth in malignant mesothelioma.
Sage EK; Kolluri KK; McNulty K; Lourenco Sda S; Kalber TL; Ordidge KL; Davies D; Gary Lee YC; Giangreco A; Janes SM
Thorax; 2014 Jul; 69(7):638-47. PubMed ID: 24567297
[TBL] [Abstract][Full Text] [Related]
13. Mesenchymal stem cells are efficiently transduced with adenoviruses bearing type 35-derived fibers and the transduced cells with the IL-28A gene produces cytotoxicity to lung carcinoma cells co-cultured.
Suzuki T; Kawamura K; Li Q; Okamoto S; Tada Y; Tatsumi K; Shimada H; Hiroshima K; Yamaguchi N; Tagawa M
BMC Cancer; 2014 Sep; 14():713. PubMed ID: 25255777
[TBL] [Abstract][Full Text] [Related]
14. Combination of vorinostat and adenovirus-TRAIL exhibits a synergistic antitumor effect by increasing transduction and transcription of TRAIL in lung cancer cells.
Kim DR; Park MY; Lee CS; Shim SH; Yoon HI; Lee JH; Sung MW; Kim YS; Lee CT
Cancer Gene Ther; 2011 Jul; 18(7):467-77. PubMed ID: 21455254
[TBL] [Abstract][Full Text] [Related]
15. pIL6-TRAIL-engineered umbilical cord mesenchymal/stromal stem cells are highly cytotoxic for myeloma cells both in vitro and in vivo.
Cafforio P; Viggiano L; Mannavola F; Pellè E; Caporusso C; Maiorano E; Felici C; Silvestris F
Stem Cell Res Ther; 2017 Sep; 8(1):206. PubMed ID: 28962646
[TBL] [Abstract][Full Text] [Related]
16. Selective TRAIL-induced cytotoxicity to lung cancer cells mediated by miRNA response elements.
Wu G; Ji Z; Li H; Lei Y; Jin X; Yu Y; Sun M
Cell Biochem Funct; 2014 Oct; 32(7):547-56. PubMed ID: 25132116
[TBL] [Abstract][Full Text] [Related]
17. Radiotherapy sensitization by tumor-specific TRAIL gene targeting improves survival of mice bearing human non-small cell lung cancer.
Zhang X; Cheung RM; Komaki R; Fang B; Chang JY
Clin Cancer Res; 2005 Sep; 11(18):6657-68. PubMed ID: 16166445
[TBL] [Abstract][Full Text] [Related]
18. Eliminating established tumor in nu/nu nude mice by a tumor necrosis factor-alpha-related apoptosis-inducing ligand-armed oncolytic adenovirus.
Dong F; Wang L; Davis JJ; Hu W; Zhang L; Guo W; Teraishi F; Ji L; Fang B
Clin Cancer Res; 2006 Sep; 12(17):5224-30. PubMed ID: 16951242
[TBL] [Abstract][Full Text] [Related]
19. Gene therapy using TRAIL-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma.
Kim SM; Lim JY; Park SI; Jeong CH; Oh JH; Jeong M; Oh W; Park SH; Sung YC; Jeun SS
Cancer Res; 2008 Dec; 68(23):9614-23. PubMed ID: 19047138
[TBL] [Abstract][Full Text] [Related]
20. Mesenchymal Stem Cells Engineered to Secrete Pigment Epithelium-Derived Factor Inhibit Tumor Metastasis and the Formation of Malignant Ascites in a Murine Colorectal Peritoneal Carcinomatosis Model.
Yang L; Zhang Y; Cheng L; Yue D; Ma J; Zhao D; Hou X; Xiang R; Cheng P
Hum Gene Ther; 2016 Mar; 27(3):267-77. PubMed ID: 26756933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
